Benign Paroxysmal Positional Vertigo (BPPV)
Conditions
Interventions
Control group:Shugan Zhixuan Decoction Granule Placebo
Experimental group:Shugan Zhixuan Decoction Granule Preparation
Sponsors
Dongfang Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet the definitive diagnostic criteria for primary BPPV; (2) Successful CRP repositioning with residual dizziness (RD) present; (3) RD duration = 2 weeks; (4) Meet the diagnostic criteria for syndrome of liver stagnation and spleen deficiency; (5) Aged between 18 and 70 years old and both genders are eligible; (6) Participants have been fully informed about the study and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Mixed-type BPPV involving 2-3 semicircular canals; (2) Inability to complete mCTSIB or SVV testing due to physical disabilities or other reasons; (3) Concurrent with other severe primary diseases in other organs or systems or mental illnesses; (4) Pregnant and lactating women as well as those with recent plans for pregnancy; (5) Sensitive constitution with known intolerance to the medications used in this study; (6) Participation in other drug clinical studies within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dizziness Handicap Inventory; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective Visual Vertical Test;Modified Clinical Test of Sensory Integration and Balance; | — |
Countries
China
Contacts
Public ContactDing Lei
Dongfang Hospital of Beijing University of Chinese Medicine
Outcome results
None listed